US Archives - Page 4 of 110 - European Medical Journal

Increased Demyelination Risk in Biologic Therapy for Rheumatic Diseases

A concerning increase in the incidence of central nervous system (CNS) demyelination among patients undergoing biologic treatments for rheumatologic diseases has been revealed by a new study.

JAK Inhibitors for Atopic Dermatitis: Does Weight Affect Outcomes?

A recent nationwide study conducted in Italy provides important insights into how body weight may influence the efficacy of JAK inhibitors in treating moderate-to-severe atopic dermatitis (AD).

Could Microbiome Interventions Be the Future of Acne Treatment?

The growing body of research on the gut-skin axis and human microbiome has sparked increasing interest in microbiome-modulatory agents as potential treatments for acne vulgaris.

IL-17: Unraveling the Story of Inflammation in SpA

Learn how IL-17 drives inflammation in spondyloarthritis at CCR East 2025…

Pilot Study Links Lymphoedema Symptoms to Altered Drainage Pathways

A pilot study using indocyanine green lymphography (ICG-L) has provided new insight into how head and neck cancer (HNC) treatments disrupt lymphatic drainage and contribute to lymphoedema, highlighting an often-overlooked source of physical and neurological symptom burden among survivors.

AI-Powered MRI Tool Distinguishes Parkinsonian Syndromes

Deep learning applied to multimodal MRI may significantly improve early differentiation between Parkinson’s disease and multiple system atrophy, offering a potential breakthrough in diagnosing parkinsonian syndromes.

Urine Compounds Non-Invasive and Detect COPD Early

Urinary volatile organic compounds (VOCs) may offer a non-invasive way to predict chronic obstructive pulmonary disease (COPD) risk, according to new findings from a national observational study using NHANES data.

Lyme Vaccine Uptake May Stall Without HCP Buy-In

Healthcare provider support for Lyme disease vaccination has declined since 2018, raising concerns about rollout readiness as the first vaccine nears approval.

Low INR Levels Raise Risk of Recurrent Arterial Thrombosis in APS

Maintaining an INR between 2.5 and 3.5 may significantly reduce the risk of recurrent thrombotic events in patients with primary antiphospholipid syndrome (APS), particularly arterial events, according to a new retrospective study.

Adnexal Tumors in Dark Skin Pose Diagnostic Hurdles

Dermoscopy traits of adnexal tumors in patients with darker skin tones may closely mimic features of malignant neoplasms, creating significant diagnostic uncertainty for clinicians.